Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-11052-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Ting Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China. Hauptthemen laut MEDLINE: ErbB Receptors, Antineoplastic Agents, Pyrimidines, Drug Design. Die Arbeit nennt 39 Literaturangaben. Gefördert von: GZU (Guizhou University) Found for Newly Enrolled Talent.
Abstract (Originalsprache)
To overcome T790M mutation, a novel series of 4-indazolypyrimidine derivatives were developed as novel EGFR inhibitors employing a scaffold hopping drug design strategy. The biological activities of the target compounds were evaluated against two tumor cell lines (A431 and NCI-H1975), normal cell 2BS and EGFRT790M/L858R kinase. The results indicated that the majority of the compounds exhibited promising antitumor activity and low toxicity. Specifically, compounds 4e and 4s displayed the highest efficacy, with IC50 values of 0.55 μM and 0.47 μM, respectively. Moreover, compounds 4e and 4s demonstrated exceptional activity against EGFRT790M/L858R, with IC50 values of 12.04 and 28.79 nM. Additionally, further studies revealed that compounds 4e and 4s could induce apoptosis in NCI-H1975 cells and arrest the cells in the G2/M phase. Molecular docking studies revealed that compounds 4e and 4s could interact closely with EGFR. These findings lay the groundwork for further investigation of compounds 4e and 4s as potential EGFR inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China.
- Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, 550025, China.
- School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China. yile2021@163.com.
- Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, 550025, China. yile2021@163.com.
Förderung
- GZU (Guizhou University) Found for Newly Enrolled Talent
Zitieren
APA
Yang, T., He, X., Wu, T., Zhu, W., Long, Z., & Le, Y. (2025). Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors. Molecular Diversity. https://doi.org/10.1007/s11030-024-11052-y
Vancouver
Yang T, He X, Wu T, Zhu W, Long Z, Le Y. Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors. Molecular Diversity. 2025. doi:10.1007/s11030-024-11052-y
BibTeX
@article{Yang2025,
author = {Yang, Ting and He, Xiaoling and Wu, Ting and Zhu, Wenqiang and Long, Zhiwu and Le, Yi},
title = {Design, synthesis and antitumor activity of 4-indazolylpyrimidine derivatives as EGFR inhibitors},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-11052-y}
}
EUVIMED